HOMA-IR Index and Pediatric Psoriasis Severity-A Retrospective Observational Study.
Adelina Maria SendreaDenis IorgaMihai DascăluAlina SuruCarmen Maria SalavastruPublished in: Life (Basel, Switzerland) (2024)
Psoriasis is a chronic inflammatory disease with specific cutaneous and nail lesions. Recent data has emphasized its systemic nature, highlighting metabolic conditions found in patients. Insulin resistance was identified in adult psoriasis, sometimes related to psoriasis severity. Data regarding this relationship in children are limited. Consequently, we tested the association between the Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) and Psoriasis Area and Severity Index (PASI) using a retrospective dataset of 43 children with various types of psoriasis. First, we attempted to replicate the relationship between the HOMA-IR and PASI. Second, we explored potential associations between these variables and others in the dataset. The results illustrated no association between HOMA-IR and PASI ( p -value = 0.512). The exploratory findings hinted at a connection between nail pitting and insulin resistance ( p -value = 0.038), yet Bonferroni adjustments suggested the risk of a false-positive finding. Noteworthy associations were found between the HOMA-IR and body mass index (BMI) ( p -value = 0.001), the PASI and quality of life impairment ( p -value = 0.005), and psoriasis severity and type ( p -value = 0.001). The null hypothesis that insulin resistance in children is not positively associated with psoriasis severity cannot be rejected. Pilot estimates of variables and covariates of interest are provided for further confirmatory studies assessing this hypothesis.
Keyphrases
- high fat diet induced
- insulin resistance
- body mass index
- metabolic syndrome
- skeletal muscle
- polycystic ovary syndrome
- young adults
- type diabetes
- atopic dermatitis
- big data
- oxidative stress
- newly diagnosed
- ejection fraction
- glycemic control
- artificial intelligence
- prognostic factors
- human health
- case control
- childhood cancer